Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs Reddit Inc — how do they compare? Adaptive Biotechnologies Corp trades at $19.85 (market cap $3.33B), while Reddit Inc trades at $193.39 (market cap $38.39B). The key difference: Reddit Inc is far larger — about 11.5× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | RDDT | |
|---|---|---|
Market Cap | $3.33B | $38.39B |
Sector | Health | Media |
52-Week High | $22.37 | $270.71 |
52-Week Low | $10.24 | $121.84 |
Enterprise Value | $3.19B | $35.64B |
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
Reddit (RDDT) trades at $200.67, up 3.13% today, reflecting strong momentum. The stock shows a bullish technical stance with moving averages aligned positively, though the RSI suggests potential overbought conditions. Fundamentally, the company exhibits robust revenue growth, with 2025 revenue at $2.2B and net income of $529.72M, supported by high gross margins of 91.37%. Recent earnings have mostly beaten expectations, and analyst sentiment is overwhelmingly positive with a consensus price target of $229.11. News highlights focus on AI safety initiatives and advertising growth.
The outlook for RDDT is favorable, driven by strong financial performance, expanding user engagement, and strategic AI investments. Key opportunities include sustained revenue growth and market share gains in social media. Risks involve competitive pressures, reliance on advertising revenue, and market volatility. With no sell ratings and solid cash flow generation, the stock presents a compelling case for growth-oriented investors, though valuation multiples remain elevated.
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →